BioCentury
ARTICLE | Financial News

Cascadian Therapeutics completes private placement of convertible preferred stock

June 27, 2016 7:00 AM UTC

Cascadian Therapeutics Inc. (NASDAQ:CASC), Seattle, Wash. Business: Cancer Date completed: 2016-06-23 Type: Private placement of convertible preferred stock Raised: $13.8 million Shares: 17,250 Price:...